Imunon to Hold Third Quarter 2022 Financial Results and Business Update Conference Call on Monday, November 14, 2022
LAWRENCEVILLE, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) — Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug-development…
LAWRENCEVILLE, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) — Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug-development…
– Can now test 1,000 employees across six sites as required, with each test always…
LEXINGTON, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in…
JUPITER, Fla., Nov. 07, 2022 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
BERKELEY HEIGHTS, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
Early, rapid, and sustained efficacy across wide range of patients with evidence of disease modification…
Ibrexafungerp demonstrates activity against deadly fungal pathogens included in the World Health Organization’s (WHO) first…
FREMONT, CA, Nov. 07, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ:…
ZUG, Switzerland, Nov. 07, 2022 (GLOBE NEWSWIRE) — Aphaia Pharma, a clinical-stage company harnessing precision-targeted…
SAN DIEGO, Nov. 07, 2022 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
CAMBRIDGE, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage…
• Signs of intra-tumor pro-inflammatory state in patients• Temferon™ induced immune system reset in preclinical…
BELTSVILLE, Md., Nov. 07, 2022 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company…
Initial clinical data of AHR antagonist, IK-175, shows treatment is well-tolerated and demonstrates anti-tumor activity…
Preclinical data demonstrate genetic and epigenetic reprogramming can ameliorate T cell exhaustion and enhance stem-like…
Comprehensive correlative science findings from patients treated with AFM24 monotherapy indicate an activation of NK…
CORAL GABLES, Fla., Nov. 07, 2022 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a…
CAMBRIDGE, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage…
Clinically Meaningful and Durable Activity in Largest Cell Therapy Clinical Trial in Patients with Melanoma…
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical…